FMRO > Funding for Research > Application Forms
Page last updated May 11, 2012
We are pleased to assist the research community in identifying potential sources of funding through the provision of information posted here:
- For information on the status of current applications, ethical reviews or research funds administered at the University of Toronto, don't forget to visit My Research On-line (MROL). For information on accessing this service or setting up a new account, please click here.
- Please note, all grants requiring the Dean’s signature should be brought to the Faculty of Medicine Research Office in the Medical Sciences Building, Room 2331 to the attention of MaryAnn DeFrancis or Cindy Faber.
- Also, our office offers a grant editing service for researchers submitting proposals to tri-council or any other funding agency. For more information, please contact Della Saunders della.saunders@utoronto.ca.
- Recently received news and updates are posted below and sent via email to our list-serve. To join click here.
"What's New in Research Funding"
Comprehensive funding opportunities may be searched through these sites:
- Community of Science Database
- University of Toronto Research & Innovation "Funding Sources"
- University of Toronto Research & Innovation Awards, Honours & Prizes Opportunities Database
- Sign up for University of Toronto Research & Innovation "Research Alerts!"
Recently Received News and Updates:
May 11, 2012
- SAVE THE DATE! : Faculty of Medicine Grant Writing Workshop - June 21, 2012. The Faculty of Medicine will be hosting our annual Grant Writing Workshop on Thursday, June 21, 2012, from 1 to 4:30pm. This year, we will have a special focus on grant writing for CIHR and NSERC opportunities and panel discussions in basic and clinical science areas, population health, health services and knowledge translation! The workshop will take place in the Medical Sciences Building, 1 King's College Circle. Registration is now open. Please register at http://www.medresearch.utoronto.ca/GWW_registration.html.
- The Collaborative Doctoral Program in Global Health (CPGH) at the University of Toronto. This program offers doctoral students the opportunity to develop cooperative and interdisciplinary graduate education and research in Global Health. We view global health as an integrative construct that focuses on the inter-relationships among local, regional, national, and international factors influencing health and the effective interventions and policies that will address these factors. This collaborative program enhances the student experience by offering a broad base of faculty expertise and an opportunity to share research ideas and results from multiple disciplinary perspectives. Deadline for Submissions: May 18, 2012.
- CIHR : The following is a list of funding opportunities which CIHR and its partners posted between March 29 and May 9, 2012. To view these opportunities, please use
the CIHR Funding Opportunity Database
- Other: Best Brains Exchange Travel Awards (2012-2013)
- Other: CH.I.L.D.-CIHR Inflammatory Bowel Disease Network
- Other: CIHR Café Scientifique Program (2012)
- Other: Healthcare Renewal Policy Analysis
- Other: Institute Community Support Grants and Awards (2012-2013)
- Other: Canada Graduate Scholarships – Michael Smith Foreign Study Supplement (2012-2013)
- Other: Core Clinical Centers for the Cardiothoracic Surgical Trials Network (CTSN)
- Other: Science Policy Fellowships (Fall 2012 Competition)
- Other: Travel Awards - Institute Community Support (Spring 2012 Competition)
- Team Grant: China-Canada Initiative on Alzheimer's Disease and Related Disorders (2012)
- Team Grant: Terry Fox New Frontiers Program in Cancer (2012-2013)
- NSERC : 2012 Strategic Network Grants .This Program fosters the increased participation of Canadian-based companies and government organizations in academic research, increase training and qualified personnel in targeted areas, generate new knowledge with strong potential to strengthen Canada’s industrial base, generate wealth, create employment and/or influence public policy in areas of strategic importance and enhance Canada’s economy, society and/or environment within the next 10 years. Applicants can request between $2.5m and $5m over 5 years. Internal Deadline for LOIs: June 12, 2012.
- Invitation to meet with Dendreon Corporation : “Developing Targeted Therapies for Cancer Patients”. The Innovations & Partnerships Office (IPO) is pleased to host one-on-one meetings with Dendreon Corporation to be held on Friday June 8, 2012. The theme of these meetings will focus on collaborative opportunities for the development of new innovative assays related to Dendreon’s core technology. Click here for details. If you would like to meet with senior Dendreon Corporation representatives to discuss possible collaborations related to any of the described areas of interest, please contact Peter Azmi (peter.azmi@utoronto.ca) with a short description of a proposed research partnership opportunity by May 25, 2012.
- Canada-Latin America and the Caribbean Research Exchange Grants Program. The purpose of this program is to strengthen international partnerships and networks among academic researchers from Canada, Latin America and the Caribbean. This program is designed to support small collaborative research activities that will contribute to the creation, dissemination and application of knowledge in at least one of IDRC’s programming areas. Please contact krista.montgomery@utoronto.ca for more information. Internal Deadline: June 26, 2012.
- U.S. Department of Defense : Fiscal Year 2012 recently released Funding Opportunities. Detailed descriptions of each of the funding opportunities, evaluation criteria, and submission requirements can be found in the respective Program Announcements.
- Amyotrophic Lateral Sclerosis Association (ALS Association) : Clinical Research Pilot Study. This request for proposals (RFP) seeks to fund pilot clinical studies to obtain preliminary clinical data which will support applications to the National Institutes of Neurological Disorders and Stroke (NINDS) for subsequent larger clinical trials of an intervention to treat or prevent ALS. Deadline for LOIs: May 28, 2012.
- National Marfan Foundation (NMF) : Grant Program for Researchers with Faculty Appointments. Applications are being requested for a one- or two-year grant for basic or clinical research. The grant program is designed to provide financial support for investigators studying any or all disciplines involved in Marfan syndrome and related disorders. Deadline for Applications: June 11, 2012
- LAM Foundation : Established Investigator Awards and Pilot Project Awards. Examples of competitive LAM proposals include those that focus on the genetic regulation of smooth muscle growth or the development of a smooth muscle cell line that is representative of the LAM lesion. Mechanistic, hypotheses-driven approaches of all types are welcomed. Formalin-fixed LAM tissues, dispersed LAM lung cells, genetic probes and other reagents are available. Deadline for LOIs: July 30, 2012.
- National Institutes of Health (NIH) : For support with NIH proposals, please consult the How to Apply for NIH page. Please also review the The Research Project Grant (R01).
- For additional submission information please contact Krista Montgomery.
- Requests for Applications and Program Announcements:
- Exploratory/Developmental Clinical Research Grants in Obesity (R21). Deadline: Multiple dates, see announcement.
- Rapid Assessment Post-Impact of Disaster (R03). Also available in a (R21 mechanism) Deadline: Multiple dates, see announcements.
April 30, 2012
- Dairy Farmers of Canada (DFC) : Dairy Research Cluster 2. Dairy Farmers of Canada (DFC) is inviting Letters of Intent from all Canadian Scientists for the Dairy Research Cluster, a program that DFC has partnered with the Canadian Agri-Science Clusters Initiative of Agriculture and Agri-Food Canada (AAFC) as part of the Growing Forward strategic framework since 2010. Innovation with focuses on knowledge translation and/or technology transfer is considered a high priority in Growing Forward 2 (2013-2018). Deadline for Letter of Intent: June 1, 2012.
- Pfizer, Inc. : Global Research Awards for Nicotine Dependence (GRAND) 2012 The mission of the GRAND Program is to advance the understanding of the mechanisms of tobacco and nicotine dependence and its treatment. To provide more balance for the overall program, in 2012, research projects should aim to provide information that could directly advance the use of pharmacotherapy in clinical practice. Deadline for Applications: June 15, 2012.
- Fox Foundation for Parkinson's Research, Michael J. (MJFF) : Biomarker Development. MJFF would like to continue its investments in the discovery and development of Parkinson's disease biomarkers. Biomarker discovery is essential to build these set of tools used to better inform clinical trials. MJFF is also calling for applications for their Dyskinesia Challenge - Identification and Testing of Novel Targets. Deadline for submissions is continuous.
- Society of Surgical Oncology (SSO) : Clinical Investigator Award in Breast Cancer Research. The purpose of this award is to promote patient-oriented breast cancer research conducted by surgical oncologists in clinical and translational science. Deadline for Applications: July 9, 2012.
- National Brain Tumor Society (NBTS) : Innovation Research Grant. National Brain Tumor Society seeks Letters of Intent (LOI) for transformative or catalytic scientific research projects that will significantly move the field forward toward effective brain tumor therapies. Innovation Grants respond to the brain tumor community's need for a rapid review process to support highly innovative research projects including those that are "out-of-the-box." Deadline for Letters of Intent: Continuous.
- Fanconi Anemia Research Fund : Research Grants. Principal investigators, post-doctoral fellows, or grant coordinators may request a grant application packet. Grant proposals may be submitted at any time throughout the year. the Fund has issued the following RFA’s: HPV Serology Among Fanconi Anemia Patients (New!); Head and Neck Carcinogenesis; and an RFA for Endocrine Organ Dysfunction.
- Spinal Research : ISRT STR18 Call for Proposals. Research proposals are called for that address or help identify clinically relevant effective treatments in either (i) severe or (ii) chronic spinal cord injuries. Please note, proposals that can show they address both criteria are especially welcomed. Preference will be given to applications that involve studies in the adult mammalian spinal cord. Deadline for Letters of Intent: June 8, 2012
- Workers Compensation Board, Manitoba : Research Funding Program. The WCB is now accepting applications for funding under the Research and Workplace Innovation Program. Qualified applicants should submit proposals for either scientific research on workplace injury, illness and disease or innovative, practical solutions to improve workplace health and safety and early and safe return to work. Deadline for Applications: June 27, 2012.
- National Institutes of Health (NIH) : For support with NIH proposals, please consult the How to Apply for NIH page. Please also review the The Research Project Grant (R01).
- For additional submission information please contact Krista Montgomery.
- Requests for Applications and Program Announcements:
- Clinical Sequencing Exploratory Research (U01). Deadline for LOIs: June 26, 2012.
- FY13 NIDA Avant-Garde Award Program for HIV/AIDS Research (DP1). Deadline for applications: January 17, 2013.
- Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug (U01). Deadline for applications: May 31, 2012.
- Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability (U01). Deadline for applications: May 31, 2012.
- Pharmacokinetics Studies of Tacrolimus in Transplant Patients (U01). Deadline for applications: May 31, 2012.
- Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34). Deadline: Multiple dates, see announcements.
- Alcohol Abuse, Sleep Disorders and Circadian Rhythms (R01). Also available in a (R21 mechanism) Deadline: Multiple dates, see announcements.
- Pre-Application for the FY13 NIDA Avant-Garde Award Program for HIV/AIDS Research (X02). Deadline for applications: October 3, 2012.
- Multidisciplinary Studies of HIV/AIDS and Aging (R01). Also available in a (R03 mechanism) and an (R21 mechanism). Deadline: Multiple dates, see announcements.
April 20, 2012
- Faculty of Medicine, U of T : Grant Miller Cancer Research Grants. The Grant Miller Cancer Research Grants have been established for feasibility studies or pilot projects in cancer research. This year, it is expected that two grants with a maximum budget of $25,000 each will be available. These grants are aimed at providing a modest level of support for the testing of innovative and original ideas in preparation for the submission of complete research proposals to peer review funding agencies or foundations. They are not meant to provide funding to supplement the on-going research of applicants. The competition is open to all faculty members in the Faculty of Medicine. Please view the terms in their entirety. Deadline for Applications: May 1, 2012.
- CIHR University Delegate Message : "Budget 2012: Health Research Escapes Finance Minister’s Axe But Not Scalpel" A message from Dr. Reinhart Reithmeier, CIHR University Delegate, University of Toronto.
- Ontario Genomics Institute : OGI 2012 SPARK Program. OGI is pleased to announce the launch of its 2012 SPARK program for high-impact, high-risk, early-stage technology development projects in the Genomic Sciences. The SPARK program will provide up to four awards of $50,000 each to be used for short duration research projects of 6-12 months. Proposals should be focused on unique and innovative projects where funding would be difficult to obtain due to the early-stage nature of the proposed research and that would result in transformative technology development that will ultimately lead to a commercial product. Registration forms are due at Research Services by May 14th, 2012 for institutional signature. For more information please contact sheila.vanlandeghem@utoronto.ca
- The Banting & Best Diabetes Centre : Graduate Studentships 2012/2013. Students need only submit one application to be considered for all awards. To be eligible, the applicant must be a registered full-time graduate student in the Faculty of Medicine, University of Toronto by August 31, 2012 and must be carrying out studies in diabetes research. The applicant must be either a Canadian citizen or have permanent residence status in Ontario by August 31, 2012. The student's supervisor must hold a full-time faculty appointment with the University of Toronto and must also be a registered member of the BBDC at the time of application submission. Supervisors may submit a maximum of 2 applications for this competition. The deadline for receipt of applications is 5 p.m., Tuesday, June 5, 2012.
- U.S. Department of Defense : Recently released Funding Opportunities.
- Bill & Melinda Gates Foundation : New Biomarkers for HIV Incidence Measurement. The HIV Diagnostics team is now accepting Letters of Inquiry for the identification of novel biomarkers that can be used effectively to measure HIV incidence at the population level. They are looking for biomarkers that could be used alone or in combination, and that are at the initial development stage. Deadline for Letters of Inquiry: May 18, 2012.
- Whitney Foundation, Helen Hay : Postdoctoral Research Fellowships. The Foundation supports early postdoctoral research training in all basic biomedical sciences. To attain its ultimate goal of increasing the number of imaginative, well-trained and dedicated medical scientists, the Foundation grants financial support of sufficient duration to help further the careers of young men and women engaged in biological or medical research. The Foundation expects that fellowship training will be obtained in an academic setting. Deadline for Applications: July 16, 2012.
- DEBRA International : Epidermolysis Bullosa Research Grants. DEBRA is delighted that there are now multiple clinical trials happening around the world, focusing on the five or so key EB therapy types in development. To reflect this situation, and after consultation with the MSAP, DEBRA decided to place equal priority on translational-research grant applications that support therapy refinement, or help potential emerging treatments develop, and on continued fundamental research needed to further our understanding of EB, or discovery of novel therapeutic approaches. Deadline for Proposals: June 30, 2012
- National Marfan Foundation : Grant Program for Researchers with Faculty Appointments. Applications are being requested for a one- or two-year grant for basic or clinical research. The grant program is designed to provide financial support for investigators studying any or all disciplines involved in Marfan syndrome and related disorders. Deadline for Applications: June 11, 2012.
- American Tinnitus Association : Research Grant Program. The program financially supports scientific studies investigating tinnitus. Studies must be directly concerned with tinnitus and contribute to ATA's goal of finding a cure. Deadline for Applications: June 30, 2012.
- National Institutes of Health (NIH) : For support with NIH proposals, please consult the How to Apply for NIH page. Please also review the The Research Project Grant (R01).
- For additional submission information please contact Krista Montgomery.
- Requests for Applications and Program Announcements:
- Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01). Deadline: Multiple dates, see announcement.
- Clinical Trials Units for NIAID Networks (UM1). Deadline for LOIs: December 29, 2012.
- Pilot and Feasibility Clinical Research Grants in Diabetes, and Endocrine and Metabolic Diseases (R21). Deadline: Multiple dates, see announcement.
- Basic Research on HIV Persistence (R01). Also available in a (R21 mechanism) Deadline: Multiple dates, see announcements.
- Integrative Omics Data Analysis for Discovery in Lung Diseases (R01). Deadline: Multiple dates, see announcements.
April 2, 2012
- CIHR Reform Survey for UofT : Please take just 3 minutes to complete our survey http://www.surveymonkey.com/s/B95FLKX regarding CIHR proposed reforms. We need your answers, and as many as we can get, to build a strong Faculty-wide response to CIHR. We thank you very much for taking the time. This message is sent on behalf of Reinhart Reithmeier, UofT CIHR Delegate, and Jim Woodgett, VP Research, Mount Sinai Hospital. Questions? della.saunders@utoronto.ca. Please complete the survey by April 15, 2012.
- CIHR : The following is a list of funding opportunities which CIHR and its partners posted between March 2 and March 28, 2012. To view these opportunities, please use
the CIHR Funding Opportunity Database
- Chair: Autism Spectrum Disorders Treatment and Care Research
- Operating Grant: Collaborative Health Research Projects (NSERC Partnered) (2012-2013)
- Operating Grant: Programmatic Grants in Food and Health
- Other: China-Canada Joint Health Research Initiative (2012)
- Team Grant: Canadian Epigenetics, Environment, and Health Research Consortium (CEEHRC)
- CIHR Webinar : "Art of Writing a CIHR Application". CIHR will offer six webinar sessions on "The Art of Writing a CIHR Application" in April 2012. This year they are offering this webinar to the entire research community. In this webinar, participants will learn some tips and get insights for writing a successful application for current competitions and programs offered at CIHR, from the planning stages through writing and submitting a CIHR application. To view the list of webinar sessions or to register for a session, go to the new Facilitated Online Session (Webinar) web page on the CIHR website.
- Heart and Stroke Foundation of Canada/CIHR/Cancer Care Ontario : Training Grant in Population Intervention for Chronic Disease Prevention 2012. This Pan-Canadian training program is designed to build population intervention research by providing supplemental training to graduate trainees from a variety of disciplines. The program includes competitive annual salary stipends, a foundational course, monthly web-conferencing, an annual meeting and experiential learning opportunities. Deadline for Submissions: April 20th, 2012.
- U.S. Department of Defense : Fiscal Year 2012 recently released Funding Opportunities. Detailed descriptions of each of the funding opportunities, evaluation criteria, and submission requirements can be found in the respective Program Announcements.
- Symposium: New Genomic Approaches for Gene Discovery & Personal Treatment in Cancer. This one-day symposium will assemble in Toronto a dynamic group of local and visiting world leaders in cancer functional genomics and target validation. The visiting speakers have pioneered insertional mutagenesis and library-based forward genetic techniques for uncovering cancer driver genes and susceptibilities. Macleod Auditorium, Medical Sciences Building, UofT; April 12, 2012
- ILSI-Biomed 2012 : 11th National Life Science and Technology Week. The ILSI-Biomed 2012 conference will be held in Tel Aviv, Israel, May 21-23. This is the leading international conference covering the fast-growing field of innovation in the biomedical, health care and life sciences industries, where industry and academia join hands to learn about the latest and future developments, explore opportunities for new business ventures, meet up with old colleagues and make new contacts. Please veiw their website for complete conference details. As a bonus, the conference organizers will offer a 10% discount off registration to University of Toronto community who register through the Israel Economic Mission to Canada. This office is also planning a Canadian delegation to ILSI-BioMed. For information and registration, the contact person is: Charley Moses, Trade Development Officer Tel: +1 (416) 847-0227 x223 Email: c.moses@israeltrade.gov.il
- Canadian Celiac Association : Grants in Aid of Research in Celiac Disease. The Canadian Celiac Association is pleased to announce two awards: The J.A.Campbell Research Grant and the J.A.Campbell Young Investigator Award. Deadline for Applications: April 30, 2012.
- National Fragile X Foundation (NFXF) : Translational Research. The NFXF supports a broad range of research endeavors that will lead to better understanding, recognition, treatment and an eventual cure of children and adults with a FXD, including fragile X syndrome (FXS), fragile X-associated tremor/ataxia syndrome (FXTAS), and fragile X-associated ovarian insufficiency (FXPOI). Translational research projects focus on bringing discoveries made about the nature, causes, and consequences of Fragile X-associated Disorders into the realm of therapeutics and interventions designed to treat the symptoms or underlying deficits of those disorders. Deadline for Proposals: April 30, 2012
- Crohn's and Colitis Foundation of America, Inc. (CCFA) : Senior Research Awards. The objective of these awards is to provide established researchers with funds to generate sufficient preliminary data to become competitive for funds from other sources, such as the National Institute of Health (NIH). Proposals must be relevant to inflammatory bowel disease (Crohn's Disease or ulcerative colitis). Deadline for Letters of Intent: May 1, 2012.
- Cystic Fibrosis Foundation (CFF) : Clinical Research Awards. These awards offer support to clinical research projects directly related to Cystic Fibrosis (CF) treatment and care. Projects may address diagnostic or therapeutic methods related to CF or the pathophysiology of CF. Applicants must demonstrate access to a sufficient number of CF patients from accredited CF Foundation care centers and appropriate controls. Deadline for Letters of Intent: June 1, 2012.
- National Institutes of Health (NIH) : For support with NIH proposals, please consult the How to Apply for NIH page. Please also review the The Research Project Grant (R01).
- For additional submission information please contact Krista Montgomery.
- Requests for Applications and Program Announcements:
- Technology-Based Interventions to Promote Engagement in Care and Treatment Adherence for Substance Abusing Populations with HIV (R01). Also available in a (R34 mechanism) Deadline: Multiple dates, see announcements.
- Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases(R21). Deadline: Multiple dates, see announcement.
- Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco (R01). Also available in a (R03 mechanism) and an (R21 mechanism). Deadline: Multiple dates, see announcements.
- Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Abuse (R34). Deadline: Multiple dates, see announcement.
- Improving Translational and Basic Research to Control Itch in Humans (ITCH) (R01). Also available in a (R21 mechanism) Deadline: Multiple dates, see announcements.
- Environmental Exposures and Health: Exploration of Non-Traditional Settings (R01). Also available in a (R21 mechanism) Deadline: Multiple dates, see announcements.
- Translational Research at the Aging/Cancer Interface (TRACI) (R21). Also available in a (R01 mechanism) Deadline: Multiple dates, see announcements.
- Pilot and Feasibility Clinical Research Studies in Digestive Diseases and Nutrition (R21). Deadline: Multiple dates, see announcement.
- NHLBI Systems Biology Collaborations (R01). Deadline: Multiple dates, see announcement.
- Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01). Deadline: Multiple dates, see announcement.
- Cancer Target Discovery and Development (CTDD) Network (U01). Deadline for LOIs: May 21, 2012.
- Core Clinical Centers for the Cardiothoracic Surgical Trials Network, CTSN (UM1). Deadline for LOIs: May 13, 2012
- Research on Emergency Medical Services for Children (EMSC) (R01). Also available in a (R21 mechanism) Deadline: Multiple dates, see announcements.
- Mechanisms of Alcohol-associated Cancers (R01). Also available in a (R21 mechanism) Deadline: Multiple dates, see announcements.
- Toward an Improved Understanding of HDL Function (R01). Deadline: Multiple dates, see announcement.
- Role of the Microflora in the Etiology of Gastro-Intestinal Cancer (R01). Deadline: Multiple dates, see announcement.
- NCI Small Grants Program for Cancer Research (NCI Omnibus R03). Deadline: Multiple dates, see announcement.
- NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21). Deadline: Multiple dates, see announcement.
March 20, 2012
- Faculty of Medicine, U of T : Grant Miller Cancer Research Grants. The Grant Miller Cancer Research Grants have been established for feasibility studies or pilot projects in cancer research. This year, it is expected that two grants with a maximum budget of $25,000 each will be available. These grants are aimed at providing a modest level of support for the testing of innovative and original ideas in preparation for the submission of complete research proposals to peer review funding agencies or foundations. They are not meant to provide funding to supplement the on-going research of applicants. The competition is open to all faculty members in the Faculty of Medicine. Please view the terms in their entirety. Deadline for Applications: May 1, 2012.
- CIHR STAGE (Strategic Training Program for Advanced Genetic Epidemiology) : Dalla Lana School of Public Health invites applications from qualified pre- and postdoctoral candidates for a new training and career development opportunity. The program, hosted at the University of Toronto Dalla Lana School of Public Health, is designed to cross-train individuals at the interface of genetics and population health sciences in genetic epidemiology and statistical genetics—two disciplines facing a massive shortage of qualified individuals in Canada and elsewhere. The program offers a unique and enriched training experience, plus internships, exchanges, competitive stipends, top-ups, and merit awards. Next application deadline: April 12, 2012. For additional application deadlines and more information, visit www.stage.utoronto.ca.
- Terry Fox Research Institute and CIHR : Recently Announced Funding Opportunities.
- The Terry Fox New Investigators Award (2012). The Terry Fox Research Institute is pleased to announce a new competition for Terry Fox New Investigators. The purpose of this award is to provide outstanding young researchers with support as they develop their career as independent research scientists or clinician scientists and to undertake high-quality research into cancer in close collaboration with established Terry Fox research teams. Deadline Application Summaries: April 23, 2012
- The Terry Fox New Frontiers Program in Cancer at CIHR - Pre-Announcement. These grants of between $750,000 and $1.5 million per year are awarded to groups of investigators to support new frontiers in Canadian cancer research (i.e., breakthrough and transformative biomedical, clinical and translational research which may form the basis for innovative cancer prevention, diagnosis and/or treatment). Total awarded annually: $12 million. The full description of the funding opportunity and instructions on how to apply will be posted on the CIHR website around mid-April.
- 2012 NSERC Collaborative Health Research Projects (CHRP) Program : The CHRP program supports focused collaborative research projects involving any field of the natural sciences or engineering and the health sciences. Successful projects must be novel and lead to health benefits for Canadians, more effective health services, or economic development in health-related areas. The proposed projects may range from fundamental knowledge creation to research on knowledge application relevant to industry or public policy. The CHRP program is jointly funded by NSERC and the CIHR. NSERC will be managing the application process. Additional projects related to the strategic priorities of CIHR Institutes may also be supported through this program. Internal Deadline for completed Notice of Intent: April 16, 2012. An information session will be held on Tuesday, April 3, 2012, from 3 pm to 5 pm in Room TZ 6 Imperial Oil Lecture Theater, Tanz Building, 6 Queen’s Park Cres. W., Please RSVP by March 30th to Martina Simmonds, martina.simmonds@utoronto.ca
- American Academy of Pediatrics : Neonatal Resuscitation Program. Funds are available from the NRP to support research that furthers knowledge in the area of neonatal resuscitation. These funds may be used to generate pilot data to allow the investigator to develop the basis for an application for independent research support through conventional granting mechanisms. Deadline for Letters of Intent: May 4, 2012.
- Progeria Research Foundation : Medical Research Grants. The Foundation awards grants to applicants who seek to conduct research to find the cause, treatment, or cure for Hutchinson- Gilford Progeria Syndrome. Submission Deadline: May 4, 2012
- Batten Disease Support and Research Association (BDSRA) : International Project Grant. The BDSRA is has announced that funds are available to conduct research directly relevant to the development of treatment of lysososomal storage and neurodegenerative diseases, specifically, Neuronal Ceroid Lipofuscinoses (NCL). Submission Deadline: May 25, 2012.
- Fondation Armand-Frappier : Postdoctoral Fellowships. These fellowships (minimum $36,000 per year) are for candidates wishing to pursue their training with one of the research professors at the INRS - Institut Armand-Frappier, a university centre specializing in graduate programs in the following areas: 1)Infectious diseases, immunity, cancer and epidemiology 2)Environmental toxicology and pharmachemistry 3)Environmental biotechnology. Deadline for Submissions: April 13, 2012.
- National Institutes of Health (NIH) : For support with NIH proposals, please consult the How to Apply for NIH page. Please also review the The Research Project Grant (R01).
- For additional submission information please contact Krista Montgomery.
- Requests for Applications and Program Announcements:
- Partnerships for Interventions to Treat Chronic, Persistent and Latent Infections (R21/R33). Deadline for LOIs: June 13, 2012.
- Developing Innovative Methodologies and Device-Specific Infrastructure through the Medical Device Epidemiology Network: Applications for Medical Countermeasure-Associated Devices (U01). Deadline for Submissions: April 30, 2012.
- Exploratory Laboratory and Analysis Projects in Parkinsons Disease Biomarkers (U18). Deadline for LOIs: April 23, 2012
- Studies in Parkinson's Disease Biomarkers Discovery (U01). Deadline for LOIS: April 23, 2012.
- NIDCD Phase I/II/III Clinical Trials in Communication Disorders (U01). Deadline: Multiple dates, see announcement.
- NIDCD Planning Grant for Phase III Clinical Trials in Communication Disorders (U34). Deadline: Multiple dates, see announcement.
March 6, 2012
- CIHR : Recently Announced Funding Opportunities.To view these opportunities, please use
the CIHR Funding Opportunity Database
- Catalyst Grant: Health Services and Systems for an Aging Population
- Chair: GlaxoSmithKline Partnered (2012-2013)
- Dissemination Events: Spring 2012 Competition and Priority Announcements
- Other: PHAC/CIHR Influenza Research Network
- Planning Grants: Spring 2012 Competition and Priority Announcements
- Team Grant: Community-Based Primary Healthcare
- Priority update to the CIHR Grants and Awards Guide The CIHR Grants and Awards Guide was updated. CIHR has revised its policy on limiting training award recipients from accepting awards from other sources in order to better align its policies with the Tri-Agency policy on stipends paid from grants. Changes outlined in the Guide's Summary of Changes are effective on the date of posting and supersede the previous version of the Guide. Effective March 1, 2012.
- Bill & Melinda Gates Foundation : Grand Challenges Explorations Round 9. Grand Challenges Explorations is an initiative to encourage innovative and unconventional global health and development solutions. New topics include "New Approaches for the Interrogation of Anti-malarial Compounds" and "Aid is Working. Tell the World". Proposal Deadline: May 15, 2012.
- U.S. Department of Defense : Fiscal Year 2012 recently released Funding Opportunities. Detailed descriptions of each of the funding opportunities, evaluation criteria, and submission requirements can be found in the respective Program Announcements.
- Wellcome Trust : Principal Research Fellowships. Principal Research Fellowships are the most prestigious of the Wellcome Trust's personal awards and provide long-term support for researchers of international standing. The fellowships are particularly suitable for senior researchers currently based overseas who wish to work in the United Kingdom or Republic of Ireland. Successful candidates will have an established track record in research at the highest level. Deadline for Expressions of Interest: Continuous.
- National Institutes of Health (NIH) : For support with NIH proposals, please consult the How to Apply for NIH page. Please also review the The Research Project Grant (R01).
- For additional submission information please contact Krista Montgomery.
- Requests for Applications and Program Announcements:
- NIH Blueprint for Neuroscience Research Grand Challenge: Discovering Novel Drugs for Disorders of the Nervous System (U01). Deadline for LOIs: May 8, 2012.
- Getting from Genes to Function in Lung Disease (R01). Deadline: Multiple dates, see announcement.
- Research on the Health of LGBTI Populations (R01). Also available in a (R03 mechanism) and an (R21 mechanism). Deadline: Multiple dates, see announcements.
- Collaborations for Macromolecular Interactions in Cells (R01). Deadline for LOIs: May 14, 2012.
- Research Networks for Macromolecular Interactions in Cells (U54). Deadline for LOIs: May 14, 2012.
- Harnessing Advanced Health Technologies to Drive Mental Health Improvement (R01). Also available in a (R34 mechanism) Deadline LOIs: May 22, 2012.
February 21, 2012
- Preeclampsia Foundation : Vision Grant Award Program. Vision Grants are intended to provide initial funding for innovative ideas focused on the pathophysiology, diagnosis or treatment of preeclampsia, HELLP syndrome and other hypertensive disorders of pregnancy that might otherwise not be pursued due to lack of funding. All novel, well-considered research topics are encouraged. Deadline for Applications: May 18, 2012.
- Fox Foundation for Parkinson's Research, Michael J. (MJFF) : Target Validation - Edmond J. Safra Core Program for PD Research. Research into the etiology and pathophysiology of Parkinson's Disease (PD) has identified an increasing number of genetic and cellular targets where therapeutic intervention could benefit people with PD. However, translation of scientific discoveries into therapeutic interventions requires additional applied work. Specifically, validation studies must be done to determine whether manipulating the availability or function of a biological target can impact a disease-relevant pathway and ultimately demonstrate beneficial potential. Deadline for Prelimary Proposals: May 31, 2012.
- National Institutes of Health (NIH) : For support with NIH proposals, please consult the How to Apply for NIH page. Please also review the The Research Project Grant (R01).
- For additional submission information please contact Krista Montgomery.
- Requests for Applications and Program Announcements:
- NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genetic Research Centers (GRCs)(U01). Deadline for LOIs: March 30, 2012.
- Stem Cell Approaches to Developing New Therapies for Ocular Diseases(R04). Deadline for LOIs: July 2, 2012.
- Development of Measures to Determine Successful Hearing Health Care Outcomes (R01). Deadline: Multiple dates, see announcement.
- Eradication of HIV-1 from CNS Reservoirs: Implications for Therapeutics (R01). Also available in a (R21 mechanism) Deadline Letters of Intent: August 12, 2012.
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements(Parent Admin Supp)Deadline: Due dates may vary.
- Ehancing Cellular Immunity in the Female Reproductive Tract(R01). Deadline: Multiple dates, see announcement.
- Functional Glycomics in HIV Vaccine Design (R01). Deadline: Multiple dates, see announcement.
- Mucosal Environment and HIV Prevention (MEHP) (R01). Deadline: Multiple dates, see announcement.
- Delivering Therapeutics to Residual Active HIV Reservoirs (R01). Deadline: Multiple dates, see announcement.
- Mental Health Research Dissertation Grant to Increase Diversity (R36). Deadline: Multiple dates, see announcement.
- Assays for High Throughput Screening (HTS) to Discover Chemical Probes in the Molecular Libraries Probe Production Centers Network (MLPCN) (X01). Deadline: Multiple dates, see announcement.
- Targeting Persistent HIV Reservoirs (TaPHIR) (R21/R33). Deadline: Multiple dates, see announcement.